rxstat › Shortages › Levetiracetam

Levetiracetam shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Levetiracetam products are in shortage in Canada (13 of 48 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 11, 2026.
Products affected
13 / 48
In shortage since
Apr 1, 2018
Est. full return
Sep 11, 2026
Reports on file
137
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-LEVETIRACETAM
750MG · TABLET · APOTEX INC
DIN 02285940 · since Jun 16, 2026, est. end Sep 11, 2026 · Disruption of the manufacture of the drug.
Active shortage
M-LEVETIRACETAM
750MG · TABLET · MANTRA PHARMA INC
DIN 02524589 · since Feb 19, 2024, no end estimate · Delay in shipping of the drug.
Active shortage
M-LEVETIRACETAM
500MG · TABLET · MANTRA PHARMA INC
DIN 02524570 · since Feb 19, 2024, no end estimate · Delay in shipping of the drug.
Active shortage
NAT-LEVETIRACETAM
500MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02440210 · since Jul 1, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-LEVETIRACETAM
250MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02440202 · since Jul 1, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-LEVETIRACETAM
750MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02440229 · since Apr 8, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACH-LEVETIRACETAM
750MG · TABLET · ACCORD HEALTHCARE INC
DIN 02399792 · since Jun 20, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-LEVETIRACETAM
250MG · TABLET · ACCORD HEALTHCARE INC
DIN 02399776 · since Mar 21, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-LEVETIRACETAM
500MG · TABLET · ACCORD HEALTHCARE INC
DIN 02399784 · since Jun 28, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
BIO-LEVETIRACETAM
500MG · TABLET · BIOMED PHARMA
DIN 02450356 · since Dec 31, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
BIO-LEVETIRACETAM
750MG · TABLET · BIOMED PHARMA
DIN 02450364 · since Apr 1, 2018, no end estimate · Delay in shipping of the drug.
Active shortage
BIO-LEVETIRACETAM
250MG · TABLET · BIOMED PHARMA
DIN 02450348 · since Apr 1, 2018, no end estimate · Delay in shipping of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Levetiracetam is currently affected by 13 active shortage reports filed with Health Canada by APOTEX INC, MANTRA PHARMA INC, NATCO PHARMA (CANADA) INC, ACCORD HEALTHCARE INC and 2 others.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Levetiracetam is classified under “ANTIEPILEPTICS” (ATC N03AX).

Recent changes

Common questions

When will Levetiracetam be back in stock in Canada?

The latest manufacturer estimate is Sep 11, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Levetiracetam in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiepileptics)

Partial shortageBrivaracetam1 of 8 reported products affected · est. return Apr 3, 2026Partial shortageCarbamazepine2 of 20 reported products affected · est. return Jun 26, 2026Partial shortageClonazepam5 of 21 reported products affectedPartial shortageLacosamide6 of 34 reported products affected · est. return Aug 10, 2026Partial shortageOxcarbazepine3 of 8 reported products affected · est. return Dec 30, 2022Partial shortagePerampanel1 of 8 reported products affected · est. return Jul 3, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.